Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Root Joseph Ernest JR	2. Issuer Name and Ticker or Trading Symbol ALLIED HEALTHCARE PRODUCTS INC [ AHPI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) QUALIPAT, 1809 JONES COVE RD.	3. Date of Earliest Transaction (MM/DD/YYYY) 11/12/2020
(Street) CLYDE, NC 28721 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								500	D
Common Stock								500	I	Individual Retirement Account

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock	$7.10							11/10/2012	11/10/2021	Common stock	750		750	D
Option to purchase common stock	$5.18							11/8/2013	11/8/2022	Common stcok	750		750	D
Option to purchase common stock	$4.62							11/14/2014	11/14/2023	Common stock	750		750	D
Option to purchase common stock	$3.16							11/13/2015	11/13/2024	Common stock	750		750	D
Option to purchase common stock	$2.34							11/12/2016	11/12/2025	Common stock	750		750	D
Option to purchase common stock	$2.26							11/10/2017	11/10/2026	Common stock	750		750	D
Option to purchase common stock	$2.22							11/9/2018	11/9/2027	Common stock	750		750	D
Option to purchase common stock	$2.13							11/8/2019	11/8/2028	Common stock	750		750	D
Option to purchase common stock	$1.17							11/7/2020	11/7/2029	Common stock	1000		1000	D
Option to purchase common stock	$7.86	11/12/2020		A		750		11/12/2021	11/12/2030	Common stock	750 (1)	$0	750	D

Explanation of Responses:
(1)	(1) - Issued pursuant to the Company's 2013 Director's Stock Option Plan.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Root Joseph Ernest JR QUALIPAT 1809 JONES COVE RD. CLYDE, NC 28721	X

Signatures
Joseph E. Root		11/16/2020
**Signature of Reporting Person		Date